Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Zied Moatemri (Ariana, Tunisia), Zied Moatemri, Nidhal Belloumi, Salsabil Dabboussi, Samira Mhamdi, Abir Hedhli, Chiraz Aichaouia, Mohsen Khadraoui, Rezaik Cheikh. Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations. Eur Respir J 2015; 46: Suppl. 59, 3607

Member's Comments

No comment yet.

Related content which might interest you: Tolerability and adherence to sublingual immunotherapy with mite vaccines with different schedule in asthmatic children Source: International Congress 2014 – More paediatric asthma Year: 2014 Tolerance of ultra-rush immunotherapy in children Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Allergic rhinitis does it have an impact on controller asthma therapy choice Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 First clinical trial of a new IgE-adsorber in allergic asthma Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma Year: 2015 Therapeutic effectpredictors during sublingual immunotherapy for Japanese seasonal allergic rhinitis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Allergen analysis of 2778 patients with allergic diseases in China Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 The impact of sublingual allergen-specific therapy on asthma control and quality of life Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Efficacy and safety of fevipiprant (QAW039) in patients with atopic asthma uncontrolled on low-dose ICS therapy Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Predictors factors for asthma in patients with rhinitis Source: International Congress 2014 – Clinical allergy Year: 2014 Comparative efficacy of different groups of drugs for the treatment of bronchial asthma in combination with allergic rhinitis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab Source: International Congress 2014 – More paediatric asthma Year: 2014 25(OH) vitamin D levels in pediatric asthma and allergic rhinitis Source: International Congress 2014 – More paediatric asthma Year: 2014 Clinical effectiveness of anti-IgE therapy in allergic severe asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014 Determinants of non-adherence to pharmacologic allergic rhinitis treatment Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Sensitization to three mites in Cuban children with allergic respiratory diseases Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Clinical characteristics of seasonal rhinitis and co-existence with asthma Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016